Media Search:



Sleep Foot Worship 1 to AVI clip29 – Video


Sleep Foot Worship 1 to AVI clip29
actors, america, apple, art, aviation, blog, blogging, bush, california, car, cartoon, cat, celebrity, charity, children, climate-change, college, comedy, co...

By: Suspense Video

See the article here:
Sleep Foot Worship 1 to AVI clip29 - Video

Girls Of Social Networking 2 – Video


Girls Of Social Networking 2

By: Pastimers

See original here:
Girls Of Social Networking 2 - Video

15 Big Social Media Mistakes Companies Make and How to Avoid Them

Social media can be a powerful marketing tool. But used the wrong way, social media sites can have a negative impact on your business -- costing you goodwill and prospective customers. So how can you create a positive impression of your business and/or your products on popular social media sites, such as Facebook, Twitter, LinkedIn, Google+ -- and avoid potentially costly social media blunders?

CIO.com asked dozens of social media experts and managers to find out. Here are their top 15 picks for the most common social media mistakes businesses make and how to avoid them.

1. Not having a social media policy."Companies who fail to provide guidelines for how their employees should conduct themselves online are dealing with a ticking time bomb," says Brandon Harig, social media strategist, Identity, an integrated public relations firm.

"By establishing expectations of how employees represent themselves online, both during work hours and after, brands not only help educate their staff on potential problems, they create a fallback when someone goes too far," Harig says.

2. Treating all social media sites as if they are the same. "Each social media channel has its own language, customs and audience," explains Simon Tam, founder and director of Marketing for The Slants, an Asian American dance rock band. So before you start using Facebook or Twitter or LinkedIn, "it's important to learn how people communicate and share on that particular network."

"Many businesses simultaneously blast the exact same message across Facebook, Twitter, Google+, LinkedIn, etc. not realizing that this comes across as fake, impersonal or spam-like," adds Raj Kadam, the cofounder and CEO of Viralheat, a social media marketing suite. To avoid coming across as fake or like a banner ad, "businesses should make the effort to understand how each individual platform works and tailor their messages and content to be platform specific."

3. Not making the most of your social media bio."On many social media platforms your bio is the first thing that someone will see," notes Hailley Griffis, a social media engagement specialist at ReSoMe (Relevant Social Media). So "be sure to include your location and website [URL] -- and be creative with the bio," if you can, she says. "If people don't know what your company does... give them a good reason to [follow or like you]."

4. Using social media as a megaphone. "Social media isn't simply a megaphone for your brand, it's a two-way street -- hence the 'social,'" explains Thom Fox, chief idea architect at consulting company the BrunoFox Group. "If you're going to do social media... dedicate personnel to monitor engagement; create an editorial calendar to generate conversations around promotions; and most importantly, be human," he says. "Interaction builds loyalty, and loyalty translates to sales."

5. Focusing on quantity of followers instead of quality. "Some companies are willing to do anything to get more followers, fans or likes from buying followers to staging a fake Twitter hack," says Dave Hawley, senior marketing director of SocialChorus, a provider of advocate marketing solutions. "The problem is, likes don't equal sales."

The solution: "Focus on quality over quantity. It's more valuable for a company to have 100,000 highly engaged advocates than 1,000,000 followers or fans," many of whom have zero interest in your brand or may not even be real, Hawley says. "A quick [or fake] fan isn't going to translate into more sales, which is why brands should focus on building loyal, lifelong fans and followers who will become brand advocates."

Go here to read the rest:
15 Big Social Media Mistakes Companies Make and How to Avoid Them

Jive sharpens social-collaboration suite's expertise directory, task management

Jive revamped the employee directory of its enterprise social-networking suite to make it easier for users to find colleagues whose expertise they can tap.

The suites Social Directory component, designed to hold detailed profiles, now lets people endorse each other, a new feature Jive feels will make even more evident the skills and expertise of employees.

Its hard to find people to get work done, said Nathan Rawlins, Jives vice president of product marketing.

In addition, when people create new groups or projects, the Jive tool will automatically suggest colleagues to invite, based on their expertise, the company said on Wednesday.

I can build up my expertise profile but now people can endorse and recommend me even for new expertise I dont have on my profile, he said.

Jives suite lets companies create whats commonly known as Facebook for the enterprise intranets that are dynamic and interactive, letting employees create profiles, participate in discussion groups and online communities, share documents and files, as well as publish blog posts, microblogs, and comments.

Jive has also expanded profiles depth by adding data on how each employee fits within the company structure, what peoples most significant contributions have been, and information on their recent activity.

The suite now offers more granular usage metrics, so that administrators can get a more detailed view of how different pages, documents, blog posts and other content were received by employees, based on indicators such as likes and comments. This sentiment analysis can be isolated via various filters, including by department and by influential employees.

To promote interaction among employees, the suite now displays a list of people who are on a page at the same time, and gives them tools to communicate in real time right in that interface.

With this latest update, Jive finished integrating the social task-management features of Producteev, which it previously acquired, so that it now offers what the company considers a full menu of capabilities for tracking what needs to get done in various projects. Jive will continue to develop and market the Producteev product as a standalone, separate tool.

Originally posted here:
Jive sharpens social-collaboration suite's expertise directory, task management

Child born with HIV still in remission after 18 months off treatment

Oct. 23, 2013 A 3-year-old Mississippi child born with HIV and treated with a combination of antiviral drugs unusually early continues to do well and remains free of active infection 18 months after all treatment ceased, according to an updated case report published Oct. 23 in the New England Journal of Medicine.

Early findings of the case were presented in March 2013 during a scientific meeting in Atlanta, but the newly published report adds detail and confirms what researchers say is the first documented case of HIV remission in a child.

"Our findings suggest that this child's remission is not a mere fluke but the likely result of aggressive and very early therapy that may have prevented the virus from taking a hold in the child's immune cells," says Deborah Persaud, M.D., lead author of the NEJM report and a virologist and pediatric HIV expert at the Johns Hopkins Children's Center.

Persaud teamed up with immunologist Katherine Luzuriaga, M.D., of the University of Massachusetts Medical School, and pediatrician Hannah Gay, M.D., of the University of Mississippi Medical Center, who identified and treated the baby and continues to see the child.

"We're thrilled that the child remains off medication and has no detectable virus replicating," Gay says. "We've continued to follow the child, obviously, and she continues to do very well. There is no sign of the return of HIV, and we will continue to follow her for the long term."

The child was born to an HIV-infected mother and began combination anti-retroviral treatment 30 hours after birth. A series of tests in the subsequent days and weeks showed progressively diminishing viral presence in the infant's blood, until it reached undetectable levels 29 days after birth. The infant remained on antivirals until 18 months of age, at which point the child was lost to follow-up for a while and, physicians say, stopped treatment. Upon return to care, about 10 months after treatment stopped, the child underwent repeated standard HIV tests, none of which detected virus in the blood, according to the report.

The child's experience, the authors of the report say, provides compelling evidence that HIV-infected infants can achieve viral remission if anti-retroviral therapy begins within hours or days of infection. As a result, a federally funded study set to begin in early 2014 will test the early-treatment method used in the Mississippi case to determine whether the approach could be used in all HIV-infected newborns.

The investigators say the prompt administration of antiviral treatment likely led to the Mississippi child's remission because it halted the formation of hard-to-treat viral reservoirs -- dormant HIV hiding in immune cells that reignites the infection in most patients within mere weeks of stopping drug therapy.

"Prompt antiviral therapy in newborns that begins within hours or days of exposure may help infants clear the virus and achieve long-term remission without the need for lifelong treatment by preventing such viral hideouts from forming in the first place," Persaud says.

Remission, defined in this case not only by absence of infection symptoms but also by lack of replicating virus, may be a stepping stone toward a sterilizing HIV cure -- complete and long-term eradication of all replicating virus from the body. A single case of sterilizing cure has been reported so far, the investigators note. It occurred in an HIV-positive man treated with a bone marrow transplant for leukemia. The bone marrow cells came from a donor with a rare genetic mutation of the white blood cells that renders some people resistant to HIV, a benefit that transferred to the recipient. Such a complex treatment approach, however, HIV experts agree, is neither feasible nor practical for the 33 million people worldwide infected with HIV.

View original post here:
Child born with HIV still in remission after 18 months off treatment